Showing results (101-110 of 187) with videos related to

Sort By:
Pageof 19
ESMO Open|August 21, 2020
Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503)Satoru Iwasa, Natsuko Okita, Aya Kuchiba, et al.
Anticancer Research|April 12, 2015
Bevacizumab and postoperative wound complications in patients with liver metastases of colorectal cancerHirofumi Utsumi, Yoshitaka Honma, Kengo Nagashima, et al.
International Journal of Clinical Oncology|February 21, 2024
Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational studyYuki Katsuya, Tatsuya Yoshida, Atsuo Takashima, et al.
Esophagus : Official Journal of the Japan Esophageal Society|March 12, 2024
Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable locally advanced esophageal and esophagogastric junctional adenocarcinomaToshiharu Hirose, Shun Yamamoto, Yoshitaka Honma, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 23, 2026
Efficacy of hydrocolloid dressing for hand-foot skin reaction: J-SUPPORT 1701 APRON trialAsako Ryu, Sadamoto Zenda, Yoichi Shimizu, et al.
Esophagus : Official Journal of the Japan Esophageal Society|June 22, 2019
Gastric mucosal injury and hemorrhage after definitive chemoradiotherapy for locally advanced esophageal cancerSatoko Monma, Ken Kato, Hirokazu Shouji, et al.
Japanese Journal of Clinical Oncology|October 16, 2019
Identification of serum microRNAs predicting the response of esophageal squamous-cell carcinoma to nivolumabKazuki Sudo, Ken Kato, Juntaro Matsuzaki, et al.
International Journal of Clinical Oncology|December 20, 2019
Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancerRyo Otsuka, Satoru Iwasa, Takako Yanai, et al.
International Journal of Cancer|July 23, 2011
Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasisYoshinori Hirashima, Yasuhide Yamada, Ukihide Tateishi, et al.
Cancer Science|February 25, 2015
Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancerNaoki Takahashi, Yasuhide Yamada, Koh Furuta, et al.
Pageof 19